Tarceva, also known by its generic name Erlotinib, is a targeted therapy used in the treatment of certain types of cancer. It falls under the category of Epidermal Growth Factor Receptor (EGFR) inhibitors, which work by blocking the action of a specific protein that helps cancer cells grow and divide.
